Twelve weeks posttreatment follow-up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin.
Hepatology (Baltimore, Md.) Apr, 2010 | Pubmed ID: 20069649